» » LOXO-292 Induces 77% ORR in RET-Positive Tumors
Edit

LOXO-292 Induces 77% ORR in RET-Positive Tumors

LOXO-292 Induces 77% ORR in RET-Positive Tumors
  1. LOXO-292 Induces 77% ORR in RET-Positive Tumors  Targeted Oncology
  2. Loxo Oncology posts improved results for newest cancer drug  Reuters
  3. New Data Helps Loxo's Cause in Developing Targeted Cancer Drugs  BloombergFull coverage

Read More ...
LOXO-292 Induces 77% ORR in RET-Positive Tumors published June 03, 2018 at 01:18AM. Original Source Link : http://www.targetedonc.com/conference/asco-2018/loxo292-induces-77-orr-in-retpositive-tumors
loading...

0 Response to "LOXO-292 Induces 77% ORR in RET-Positive Tumors"

Posting Komentar

Langganan: Posting Komentar (Atom)